Sun Pharma Advanced Research Company (SPARC) announced significant changes to its Senior Management Team, effective late March/early April 2026. Dr. Shravanti Bhowmik has resigned as VP of Operations Management, effective March 31, 2026, to take on a new role within the broader group. She will be succeeded by Mr. Narendra Lakkad, appointed as Head of Corporate Development and Operations Management starting April 01, 2026.
Senior Management Changes Approved
The Board of Directors of Sun Pharma Advanced Research Company Limited (SPARC), based on the recommendation of the Nomination and Remuneration Committee, has approved key personnel changes affecting its Senior Management Team via a circular resolution dated March 27, 2026.
Resignation of Dr. Shravanti Bhowmik
The Board has accepted the resignation of Dr. Shravanti Bhowmik from her roles as Vice President, Operations Management, and a member of the Senior Management Team. Her cessation of duties is effective from the close of business hours on March 31, 2026. Dr. Bhowmik stated in her resignation letter that she is transitioning to a new opportunity within the Sun Pharma group company.
Appointment of Mr. Narendra Lakkad
Concurrently, the Board approved the appointment of Mr. Narendra Lakkad as Head – Corporate Development and Operations Management. He will formally be designated as a Senior Management Personnel with effect from April 01, 2026.
Profile Summary of New Appointee
Mr. Lakkad brings extensive experience, holding a Master’s degree in Pharmacology. He has been associated with the Sun Pharma group since 1994. His prior roles include Senior General Manager – Business Development at Sun Pharmaceuticals Industries Ltd (SPIL) until 2013. Subsequently, from 2014 to 2018, he served SPARC as Vice President & Head – Global Business Development, Investor Relations & Corporate Communications. He most recently held roles within the main group involving Program Management and Alliance Management, and was associated with SPARC’s Specialty Portfolio until 2023.
Disclosure Details
The change involves the resignation of a personnel member and the appointment of a new one. There is no disclosure of relationship between Directors concerning the appointment of Mr. Lakkad (marked as NA).
Source: BSE
